Gilead Sciences

Gilead's Rohini Mehtani, Ph.D. Reflects on The Importance of ASH21

Multimedia with summary

As ASH21 wraps up, Gilead’s Rohini Mehtani, Ph.D. reflects on the importance of the meeting, particularly for people living with higher-risk myelodysplastic syndrome.

Russian Foundation Provides Career Guidance for Teens Living With HIV


Svetlana Izambaeva was 22 years old when she learned she had contracted HIV from her boyfriend in 2002. The news shocked her.

“I had never known anyone with HIV,” she remembers. “I thought it was somewhere distant and far away, and it surely had nothing to do with us.”

Svetlana and her boyfriend were serious and talking about marriage. When he suddenly stopped texting her one day, she was devastated. It was months later during a routine checkup at her doctor’s office that she received the diagnosis.

Gilead Sciences and Breast Cancer Awareness Month

Multimedia with summary

The SABCS brings the scientific community and advocates together to focus on the biggest needs in breastcancer, including how the disease uniquely affects Black women. , CEO of 

Saying 'Not Today' to Triple-Negative Breast Cancer: Lee Ann's Journey


For Lee Ann, learning she had Stage 4 triple-negative breast cancer (TNBC) came as a real shock. As someone who regularly had mammograms starting in her twenties, she considered herself healthy. But at age 63, after discovering a lump and an enlarged lymph node, she was now facing the most aggressive type of breast cancer.

Due to the nature of TNBC, effective treatment options are extremely limited compared with other breast cancer types. Lee Ann knew it was going to be a tough journey ahead, but she faced it with courage from the get-go and made “Not today” her mantra.

HIV Advisory Council in Australia Taps Diverse Community Perspectives


In the summer of 2019, Brent Allan, a long-time HIV advocate in Australia, met with Damien Fagan, Gilead’s regional Associate Director, HIV Medical Affairs, to discuss programs that would best serve the needs of people living with HIV.  

“A lot of programs or services sound great on paper,” Brent explained to Damien, “but in practice they might not actually deliver. The only way to know what really works is to have a finger on the pulse of the particular community.”

Gilead Sciences Ranked No. 6 overall, and No. 2 in Health Care & Life Sciences Industry, in Newsweek's List of Most Responsible American Companies

Multimedia with summary

We’re honored to be ranked No. 6 overall, and No. 2 within the Health Care & Life Sciences industry, in Newsweek’s just-released list of Most Responsible American Companies. The third annual list is comprised of 500 of the largest public corporations, and our inclusion demonstrates our ongoing commitment to Environmental, Social, and Corporate Governance (ESG) efforts.

Gildead Sciences Is Proud to Be a Presenting Partner of National AIDS Memorial's World AIDS Day: December 1, 2021

Multimedia with summary

We’re proud to be a presenting partner of National AIDS Memorial’s World AIDS Day events. Among the activities: A virtual observance and national forum with leaders on topics related to HIV/AIDS and health and social justice, community displays of the AIDS Quilt and a magical light display in the 10-acre Memorial Grove. We hope you’ll join in.  

Gilead Sciences Added to the Dow Jones Sustainability World Index

Multimedia with summary

We’re proud to be added to the Dow Jones Sustainability World Index, part of S&P Global Dow Jones Indices, based on our performance on the Corporate Sustainability Assessment. The assessment reflects our ongoing commitment to be a leader in this area as we work to discover, develop and deliver innovative therapeutics for people with life-threatening diseases.

The Importance of Self Advocacy in Breast Cancer: Janelle's Story


Janelle Goins was watching TV one evening when she discovered a small nodule in one of her breasts. But she didn’t feel overly concerned because she’s had cysts in the past.

“I thought to myself, it’s just another cyst, and it’s perfect timing because I’m already scheduled to go in for my 40-year-old mammogram,” recalls Janelle, who is Gilead’s Director of Medical Affairs for Patient Engagement.

India's Efforts to Help End Hepatitis C Starts With Prison Population


A global nonprofit is leading an effort to help eliminate the hepatitis C virus (HCV) among people who are incarcerated in India. Over the last two years, the Foundation for Innovative New Diagnostics (FIND) has been targeting the highly vulnerable group of prison inmates in the northern states of Punjab and Haryana where HCV is particularly prevalent.

“By eliminating the virus in prisons, you can prevent transmission within both the prisons and the general population and ultimately slow the spread of the virus,” explains Sanjay Sarin, Vice President of Access at FIND.


Subscribe to Gilead Sciences